[go: up one dir, main page]

BR9608313A - Carbapenema esters - Google Patents

Carbapenema esters

Info

Publication number
BR9608313A
BR9608313A BR9608313A BR9608313A BR9608313A BR 9608313 A BR9608313 A BR 9608313A BR 9608313 A BR9608313 A BR 9608313A BR 9608313 A BR9608313 A BR 9608313A BR 9608313 A BR9608313 A BR 9608313A
Authority
BR
Brazil
Prior art keywords
carbapenema
esters
carbapenema esters
Prior art date
Application number
BR9608313A
Other languages
Portuguese (pt)
Inventor
Alfred John Eglington
Stephen Frederick Moss
George Burton
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508955.3A external-priority patent/GB9508955D0/en
Priority claimed from GBGB9508956.1A external-priority patent/GB9508956D0/en
Priority claimed from GBGB9508957.9A external-priority patent/GB9508957D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9608313A publication Critical patent/BR9608313A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • C07D477/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR9608313A 1995-05-03 1996-05-02 Carbapenema esters BR9608313A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9508955.3A GB9508955D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508956.1A GB9508956D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508957.9A GB9508957D0 (en) 1995-05-03 1995-05-03 Novel compounds
PCT/EP1996/001880 WO1996034868A1 (en) 1995-05-03 1996-05-02 Esters of carbapenems

Publications (1)

Publication Number Publication Date
BR9608313A true BR9608313A (en) 1999-01-26

Family

ID=27267696

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608313A BR9608313A (en) 1995-05-03 1996-05-02 Carbapenema esters

Country Status (22)

Country Link
EP (1) EP0823910A1 (en)
JP (1) JPH11504910A (en)
KR (1) KR19990008355A (en)
CN (1) CN1185783A (en)
AR (1) AR005416A1 (en)
AU (1) AU5813996A (en)
BG (1) BG102014A (en)
BR (1) BR9608313A (en)
CA (1) CA2217990A1 (en)
CZ (1) CZ347597A3 (en)
EA (1) EA199700293A1 (en)
HU (1) HUP9801066A3 (en)
IL (1) IL118092A0 (en)
MA (1) MA23853A1 (en)
MX (1) MX9708421A (en)
NO (1) NO974994D0 (en)
OA (1) OA10632A (en)
PE (1) PE50697A1 (en)
PL (1) PL323141A1 (en)
SK (1) SK146497A3 (en)
TR (1) TR199701286T1 (en)
WO (1) WO1996034868A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902659A1 (en) 2006-06-23 2007-12-28 Pierre Fabre Medicament Sa DHA ESTER AND ITS USE IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
WO2013157583A1 (en) * 2012-04-18 2013-10-24 大日本住友製薬株式会社 Novel carbapenem compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
CA1212105A (en) * 1980-04-30 1986-09-30 Shoji Ikeda Ampicillin esters and production thereof
WO1995005380A1 (en) * 1993-08-18 1995-02-23 Sankyo Company, Limited Crystalline carbapenem derivatives
EP0725783B1 (en) * 1993-10-29 2002-12-18 SmithKline Beecham plc 2-(pyrazol-3-yl)carbapenem derivatives

Also Published As

Publication number Publication date
JPH11504910A (en) 1999-05-11
SK146497A3 (en) 1998-05-06
CZ347597A3 (en) 1998-08-12
HUP9801066A2 (en) 1998-08-28
PL323141A1 (en) 1998-03-16
MX9708421A (en) 1998-02-28
KR19990008355A (en) 1999-01-25
EA199700293A1 (en) 1998-06-25
IL118092A0 (en) 1996-09-12
NO974994L (en) 1997-10-30
PE50697A1 (en) 1997-12-18
NO974994D0 (en) 1997-10-30
AU5813996A (en) 1996-11-21
OA10632A (en) 2002-09-16
HUP9801066A3 (en) 1999-01-28
EP0823910A1 (en) 1998-02-18
CA2217990A1 (en) 1996-11-07
TR199701286T1 (en) 1998-02-21
MA23853A1 (en) 1996-12-31
CN1185783A (en) 1998-06-24
AR005416A1 (en) 1999-06-23
BG102014A (en) 1998-11-30
WO1996034868A1 (en) 1996-11-07

Similar Documents

Publication Publication Date Title
BR9609682A (en) Low-nuanced photo-disinfectants
DE69635315D1 (en) Kodeverteilvielfachzugriffskommunikationssystem
DE69635184T2 (en) VIELFACHKAPILLARFLUORESZENZSENSORANORDNUNG
DE69636827D1 (en) Spreizspektrumübertragungsgerät
DE59608860D1 (en) Sheet-
DE69623069D1 (en) Fahrzeugodometerkorrektursystem
DE69728300D1 (en) SPIRALFLUIDUMMASCHINE
DE69620833D1 (en) Kryopumpanlage
DE69612112D1 (en) FLUORED DIESTER
DE69619572D1 (en) Kabelzugvorrichtung
DE69617697D1 (en) AUFZUGSTÜRBEGRENZER
ATA135896A (en) SKIBOB
EP0861320A4 (en) SEQUESTRINE
DE69603282D1 (en) FLUORRINATED POLYISOLYANATE
DE69632434D1 (en) Strangiessenanlage
DE69623189D1 (en) Chipkartenabtaster
DE69633323D1 (en) Pyrazolylazophenolfarbstoff
BR9610022A (en) Esters
DK0863916T3 (en) Polyfluoroalkyl-tryptohantripeptid-thrombin
DE69619217D1 (en) VISCOSITÄTSHEIZUNG
DE69631954D1 (en) SPREIZSPEKTRUMNACHRICHTENÜBERTRAGUNGSSYSTEM
DE69622586D1 (en) BODENPLATTE
DE69624850D1 (en) PHIOLEVERSCHLUSSHEBER
DE69629523D1 (en) Nachintegrationsspreizspektrumempfänger
PT839024E (en) FORMULACOES DE MONENSINA

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law